OAB and nocturia
Poster Session 42
-
Location:Room Amsterdam, North Hall (Level 1)
-
Chairs:
-
Aims and objectives of this session OAB and nocturia remain important clinical challenges in an aging population. What are the new developments?
- Poster viewing of 20 minutes. Presentations will take place on stage. Standard presentations are 2 minutes in length, followed by 2 minutes for discussion. Extended presentations (*) are 3 minutes in length, followed by 3 minutes for discussion.
Institutes: 1Melbourne Health, Dept. of Rehabilitation and Sub-Acute Community Services, Parkville, Australia, 2Melbourne Health, Dept. of Rehabilitation Services, Parkville, Australia, 3Melbourne Health, Dept. of Sub-Acute Community Services, Parkville, Australia, 4Melbourne Health, Dept. of Respiratory and Sleep Medicine, Parkville, Australia, 5Melbourne Health, Dept. of Aged Care Services and Urology, Parkville, Australia
Institutes: 1University of Fukui, Dept. of Urology, Fukui, Japan, 2University of Yamanashi, Dept. of Urology, Yamanashi, Japan, 3Nagoya University Graduate School of Medicine, Dept. of Urology, Nagoya, Japan, 4National Center For Geriatrics and Gerontology, Dept. of Urology, Obu, Japan, 5Asahikawa Medical University, Dept. of Renal and Urologic Surgery, Asahikawa, Japan, 6Nihon University School of Medicine, Dept. of Urology, Tokyo, Japan, 7Sapporo Medical University School of Medicine, Dept. of Urology, Sapporo, Japan
Institutes: 1Bristol Urological Institute, Dept. of Urology, Bristol, United Kingdom, 2Ghent University Hospital, Dept. of Uro-Gynaecology, Ghent, Belgium, 3Medical University of South Carolina, Dept. of Urology, Charleston, United States of America, 4Vanderbilt University Medical Center, Dept. of Urologic Surgery, Nashville, United States of America, 5USC Institute of Urology, Dept. of Urology, Los Angeles, United States of America, 6University of Toronto, Dept. of Urology, Toronto, Canada, 7New York University, Dept. of Urology, New York, United States of America, 8Allergan Plc, Dept. of Urology, Irvine, California, United States of America, 9Allergan Plc, Dept. of Statistics, Bridgewater, United States of America, 10The Royal Hallamshire Hospital, Sheffield Teaching Hospitals, NHS Foundation Trust, Dept. of Urology, Sheffield, United Kingdom
Institutes: 1Guy’s and St Thomas’ Hospitals, Dept. of Obstetrics and Gynecology, London, United Kingdom, 2Sheffield University, Dept. of Urology Research, Sheffield, United Kingdom, 3Endpoint Outcomes, Dept. of Outcomes Research, Boston, United States of America, 4Vista Urology & Pelvic Pain Partners, Dept. of Urology, San Jose, United States of America, 5University of Tokyo, Dept. of Urology, Tokyo, Japan, 6Astellas, Dept. of Medical Affairs, Leiden, The Netherlands, 7Astellas Pharma Europe Ltd, Dept. of Medical Affairs, Chertsey, United Kingdom
Institutes: 1Paracelsus Private Medical University of Salzburg, Dept. of Scitrecs, Salzburg, Austria, 2SALK, Dept. of Urology, Salzburg, Austria, 3Balgrist, Dept. of Neuro-Urology, Zurich, Switzerland, 4University of Antwerp, Dept. of Urology, Antwerp, Belgium